These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 1736834

  • 1. [Effect of treatment schedule of an antitumor platinum complex, DWA2114R, on the antitumor activity].
    Endo K, Akamatsu K, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):223-8. PubMed ID: 1736834
    [Abstract] [Full Text] [Related]

  • 2. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K, Akamatsu K, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1992 Feb; 12(1):49-58. PubMed ID: 1567181
    [Abstract] [Full Text] [Related]

  • 3. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
    Akamatsu K, Saito H, Tsunenari T, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1993 Feb; 13(6A):2261-5. PubMed ID: 8297143
    [Abstract] [Full Text] [Related]

  • 4. [Antitumor activity of a new platinum complex (R)-(-)-2-aminomethylpyrrolidine (1,1-cyclobutane dicarboxylato) platinum (II) (DWA2114R) by its serial administration].
    Akamatsu K, Endo K, Matsumoto T, Kamisango K, Morikawa K, Koizumi M, Mitsui H, Koizumi K, Matsuno T.
    Gan To Kagaku Ryoho; 1989 May; 16(5):2039-43. PubMed ID: 2658840
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
    Nio Y, Imai S, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Tobe T.
    Anticancer Res; 1991 May; 11(2):761-7. PubMed ID: 2064331
    [Abstract] [Full Text] [Related]

  • 6. Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II).
    Endoh K, Akamatsu K, Matsumoto T, Morikawa K, Honda M, Mitsui H, Koizumi M, Koizumi K, Matsuno T.
    Anticancer Res; 1989 May; 9(4):987-91. PubMed ID: 2817826
    [Abstract] [Full Text] [Related]

  • 7. Effect of treatment schedule on antitumor activity of glycolate-0,0'-diammineplatinum(II), a new platinum derivative: comparison with cis-diamminedichloroplatinum(II).
    Suzumura Y, Kato T, Ueda R, Ota K.
    Anticancer Res; 1989 May; 9(4):1083-8. PubMed ID: 2817790
    [Abstract] [Full Text] [Related]

  • 8. [Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
    Akamatsu K, Endo K, Tsunenari T, Matsumoto T, Kaiho S, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):229-35. PubMed ID: 1736835
    [Abstract] [Full Text] [Related]

  • 9. [Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line].
    Akamatsu K, Endo K, Matsumoto T, Kamisango K, Morikawa K, Koizumi M, Mitsui H, Koizumi K, Matsuno T.
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):73-8. PubMed ID: 2404458
    [Abstract] [Full Text] [Related]

  • 10. [Flow cytometric analysis of the effect of DWA2114R on the cell cycle traverse of RPMI 8402 cells--comparison with CDDP].
    Takamoto S, Souma R.
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):469-76. PubMed ID: 1558396
    [Abstract] [Full Text] [Related]

  • 11. Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.
    Akamatsu K, Endo K, Matsumoto T, Morikawa K, Koizumi M, Koizumi K, Mitsui H.
    Jpn J Cancer Res; 1991 Jun; 82(6):724-31. PubMed ID: 1906857
    [Abstract] [Full Text] [Related]

  • 12. [Antitumor activity and toxicity of KB-5424 R, a newly developed antitumor platinum compound].
    Yamaguchi H, Kubota T, Takahara T, Takeuchi T, Furukawa T, Kase S, Josui K, Kodaira S, Ishibiki K, Abe O.
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1135-41. PubMed ID: 2053772
    [Abstract] [Full Text] [Related]

  • 13. [Antitumor effects of newly synthesized analogues of platinum (NK121) and bleomycin (NK313) in nude mice implanted human tumor].
    Yokoe H, Kanazawa H, Takahashi K, Sato K.
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):97-101. PubMed ID: 1702964
    [Abstract] [Full Text] [Related]

  • 14. Antitumor activity and cellular accumulation of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) monohydrate, in cisplatin-sensitive and -resistant murine P388 leukemia cells.
    Kamisango K, Matsumoto T, Akamatsu K, Morikawa K, Tashiro T, Koizumi K.
    Jpn J Cancer Res; 1992 Mar; 83(3):304-11. PubMed ID: 1582895
    [Abstract] [Full Text] [Related]

  • 15. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 16. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
    Bernacki RJ, Oberman EJ, Seweryniak KE, Atwood A, Bergeron RJ, Porter CW.
    Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
    [Abstract] [Full Text] [Related]

  • 17. Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
    Akamatsu K, Endo K, Matsumoto T, Kamisango K, Morikawa K, Koizumi M, Koizumi K.
    Br J Cancer; 1992 Nov; 66(5):827-32. PubMed ID: 1419625
    [Abstract] [Full Text] [Related]

  • 18. In vitro antitumor mechanism of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++) platinum(II).
    Akamatsu K, Endo K, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1991 Nov; 11(1):151-5. PubMed ID: 2018348
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL, Roberts BJ, Howard CT, Leopold WR.
    Cancer Res; 1994 Aug 15; 54(16):4412-8. PubMed ID: 8044790
    [Abstract] [Full Text] [Related]

  • 20. The interactions of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) and related compounds with deoxyribonucleic acid.
    Morikawa K, Matsumoto T, Matsuoka Y, Koizumi K.
    Chem Pharm Bull (Tokyo); 1992 Jan 15; 40(1):212-9. PubMed ID: 1576676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.